Literature DB >> 3027479

Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa.

T T Jung, S K Juhn, D Hwang, R Stewart.   

Abstract

Prostaglandins (PGs) and leukotrienes (LTs) are known to play an important role in allergic inflammatory reactions. The triad of aspirin sensitivity, nasal polyposis, and asthma led us to suspect that PGs, LTs and other arachidonic acid metabolites may be involved in the pathogenesis of nasal polyps. The purpose of this study was to determine arachidonic acid metabolites and to measure concentrations of PGs and LTs in nasal polyps and nasal mucosa. Samples of nasal polyps and nasal mucosa were obtained at the time of polypectomies and nasal procedures. Metabolites of arachidonic acid in tissue were determined by incubation of tissue-homogenates with 14C-arachidonic acid and analyses with thin-layer chromatography and high performance liquid chromatography (HPLC). Levels of PGE2, 6-keto-PGF1 alpha, thromboxane (Tx)B2, 15-hydroxyeicosatetraenoic acid (HETE), LTC4, LTB4 were measured by radioimmunoassay. The predominant arachidonic acid metabolite in both nasal polyps and mucosa with 15-HETE. The HPLC analysis showed that the predominant metabolite in nasal polyp was 15-HETE, especially in polyps from aspirin sensitive patients. Levels of 15-HETE and PGE2 were higher in polyps from patients with a history of allergy than from nonallergic patients. Levels of LTC4 and LTB4 in nasal polyps were determined. The findings of this study will help to explain biochemical basis of the pathogenesis of aspirin-sensitive nasal polyps and to develop better medical treatment for them.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027479     DOI: 10.1288/00005537-198702000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

Review 1.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

Review 2.  The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.

Authors:  Stephen M Parnes
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 3.  Pathogenesis of nasal polyps: an update.

Authors:  Rafal Pawliczak; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

4.  Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease.

Authors:  Whitney W Stevens; Anna G Staudacher; Kathryn E Hulse; Roderick G Carter; Deborah R Winter; Hiam Abdala-Valencia; Atsushi Kato; Lydia Suh; James E Norton; Julia H Huang; Anju T Peters; Leslie C Grammer; Caroline P E Price; David B Conley; Stephanie Shintani-Smith; Bruce K Tan; Kevin C Welch; Robert C Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-05-01       Impact factor: 10.793

Review 5.  Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis.

Authors:  Josep M Guilemany; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

6.  Pulmonary Function of Patients with Chronic Rhinosinusitis and the Impact of Endoscopic Sinus Surgery.

Authors:  Ahmed M Youssef; Osama G Abdel-Naby Awad; Mohamed Taha
Journal:  OTO Open       Date:  2017-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.